1. Home
  2. EXK vs NKTR Comparison

EXK vs NKTR Comparison

Compare EXK & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Endeavour Silver Corporation (Canada)

EXK

Endeavour Silver Corporation (Canada)

HOLD

Current Price

$7.93

Market Cap

2.3B

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$70.35

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXK
NKTR
Founded
1981
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
EXK
NKTR
Price
$7.93
$70.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$13.94
$146.67
AVG Volume (30 Days)
5.3M
905.1K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
$69.59
N/A
Revenue Next Year
$17.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
86.00
52 Week Low
$4.91
$21.02
52 Week High
$15.15
$109.00

Technical Indicators

Market Signals
Indicator
EXK
NKTR
Relative Strength Index (RSI) 45.93 54.95
Support Level $7.43 $64.30
Resistance Level $8.43 $76.78
Average True Range (ATR) 0.38 3.48
MACD 0.04 0.11
Stochastic Oscillator 46.94 54.12

Price Performance

Historical Comparison
EXK
NKTR

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: